Skip to main content

Want a detailed portfolio tracker?

Prothena (PRTA) P/E (2012 - 2026)

Prothena (PRTA) P/E from Dec 31, 2012 to Jul 21, 2026. The TTM Prothena (PRTA) P/E is -3.13. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Prothena (PRTA)

YearP/EChange
2026-3.13+48.39%
2025-2.11-65.42%
2024-6.09-76.88%
2023-26.34+45.31%
2022-18.13-152.13%
202134.77-906.21%
2020-4.31-46.95%
2019-8.13+208.36%
2018-2.64-70.70%
2017-9.00-26.94%
2016-12.32-52.51%
2015-25.94-87.91%
2014-214.57+1721.40%
2013-11.78+11.09%
2012-10.60N/A

Comparison Prothena (PRTA) P/E with competitors

Prothena (PRTA) P/E is -3.13.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.05%
NBYStablecoin Development Corp0.00-100.14%
ENLVEnlivex Ltd0.07-102.39%
FGENFibroGen Inc0.24-107.68%
CHRSCoherus Biosciences Inc0.85-127.15%
FBIOFortress Biotech Inc0.95-130.37%
ORMPOramed Pharmaceuticals Inc1.50-148.10%
AGENAgenus Inc3.01-196.30%
INVAInnoviva Inc3.15-200.92%
VXRTVaxart Inc3.55-213.59%
CRMDCorMedix Inc3.63-216.10%
CVACCureVac N.V.4.45-242.25%
GLPGGalapagos NV4.86-255.48%
SRPTSarepta Therapeutics Inc4.88-256.22%
ABEOAbeona Therapeutics Inc5.39-272.39%
ABUSArbutus Biopharma Corp5.60-279.05%
ZVRAZevra Therapeutics Inc5.89-288.38%
SPROSpero Therapeutics Inc6.23-299.30%
CGENCompugen Ltd6.31-302.04%
RIGLRigel Pharmaceuticals6.87-319.89%
SLXNSilexion Therapeutics Corp7.30-333.46%
OMEROmeros Corporation9.26-396.26%
AUPHAurinia Pharmaceuticals Inc9.58-406.70%
PLXProtalix BioTherapeutics Inc10.89-448.49%
ACADAcadia Pharmaceuticals Inc11.73-475.29%
TBPHTheravance Biopharma Inc12.26-492.37%
ADMAAdma Biologics Inc12.42-497.36%
HRMYHarmony Biosciences Holdings Inc13.82-542.22%
SABSSAB Biotherapeutics Inc14.14-552.34%
NAGENiagen Bioscience Inc14.82-574.16%
INCYIncyte Corp15.82-606.30%
REGNRegeneron Pharmaceuticals Inc15.86-607.39%
PBYIPuma Biotechnology Inc17.32-654.08%
CPRXCatalyst Pharmaceuticals Inc17.44-658.03%
EXELExelixis Inc17.54-661.19%
TGTXTG Therapeutics Inc18.97-706.88%
MDXGMimedx Group Inc20.55-757.65%
XOMAXOMA Royalty Corp22.87-831.97%
ARGXArgen X SE24.30-877.52%
CTMXCytomX Therapeutics Inc24.82-894.26%
XOMAOXOMA Royalty Corp25.34-911.02%
HALOHalozyme Therapeutics Inc25.62-919.94%
XOMAPXOMA Royalty Corp25.67-921.42%
VRTXVertex Pharmaceuticals Inc27.99-995.81%
RPRXRoyalty Pharma plc - Class A28.69-1017.98%
SLNOSoleno Therapeutics Inc29.02-1028.47%
ASNDAscendis Pharma A/S30.09-1062.72%
LGNDLigand Pharmaceuticals Inc - Class B37.91-1313.16%
APLSApellis Pharmaceuticals Inc39.02-1348.65%
BMRNBiomarin Pharmaceutical Inc42.21-1450.75%
KRYSKrystal Biotech Inc45.34-1550.96%
ONCBeiGene Ltd69.54-2325.24%
PHARPharming Group N.V.75.03-2500.77%
TECHBio-Techne Corp101.96-3362.60%
VCELVericel Corp109.92-3617.40%
ALNYAlnylam Pharmaceuticals Inc117.96-3874.80%
GMABGenmab140.29-4589.21%
TLXTelix Pharmaceuticals Ltd162.15-5288.78%
CORTCorcept Therapeutics Inc212.86-6911.29%